Header Logo

Connection

MARY ESTES to Capsid Proteins

Back to Details
This is a "connection" page, showing publications MARY ESTES has written about Capsid Proteins.
MARY ESTES
Connection Strength
4.853
Capsid Proteins
  1. Mapping broadly reactive norovirus genogroup I and II monoclonal antibodies. Clin Vaccine Immunol. 2015 Feb; 22(2):168-77.
    View in: PubMed
    Score: 0.442
  2. The VP8* domain of neonatal rotavirus strain G10P[11] binds to type II precursor glycans. J Virol. 2013 Jul; 87(13):7255-64.
    View in: PubMed
    Score: 0.396
  3. Norwalk Virus Minor Capsid Protein VP2 Associates within the VP1 Shell Domain. J Virol. 2013 May; 87(9):4818-25.
    View in: PubMed
    Score: 0.391
  4. A time-resolved immunoassay to measure serum antibodies to the rotavirus VP6 capsid protein. J Virol Methods. 2013 Apr; 189(1):228-31.
    View in: PubMed
    Score: 0.385
  5. Identification of Genogroup I and Genogroup II broadly reactive epitopes on the norovirus capsid. J Virol. 2005 Jun; 79(12):7402-9.
    View in: PubMed
    Score: 0.229
  6. The 3' end of Norwalk virus mRNA contains determinants that regulate the expression and stability of the viral capsid protein VP1: a novel function for the VP2 protein. J Virol. 2003 Nov; 77(21):11603-15.
    View in: PubMed
    Score: 0.205
  7. Two nonoverlapping domains on the Norwalk virus open reading frame 3 (ORF3) protein are involved in the formation of the phosphorylated 35K protein and in ORF3-capsid protein interactions. J Virol. 2003 Mar; 77(6):3569-77.
    View in: PubMed
    Score: 0.196
  8. Structural requirements for the assembly of Norwalk virus-like particles. J Virol. 2002 Apr; 76(8):4044-55.
    View in: PubMed
    Score: 0.184
  9. Sequence analysis of the VP4, VP6, VP7, and NSP4 gene products of the bovine rotavirus WC3. Virus Genes. 2002 Mar; 24(2):107-18.
    View in: PubMed
    Score: 0.183
  10. Identification of an epitope common to genogroup 1 "norwalk-like viruses". J Clin Microbiol. 2000 Apr; 38(4):1656-60.
    View in: PubMed
    Score: 0.160
  11. X-ray crystallographic structure of the Norwalk virus capsid. Science. 1999 Oct 08; 286(5438):287-90.
    View in: PubMed
    Score: 0.155
  12. Structural characterization by multistage mass spectrometry (MSn) of human milk glycans recognized by human rotaviruses. Mol Cell Proteomics. 2014 Nov; 13(11):2961-74.
    View in: PubMed
    Score: 0.108
  13. Assessment of epitope-blocking assays for measuring antibody to rotavirus. J Virol Methods. 1994 Jul; 48(2-3):293-300.
    View in: PubMed
    Score: 0.108
  14. Localization of rotavirus VP4 neutralization epitopes involved in antibody-induced conformational changes of virus structure. J Virol. 1994 Jun; 68(6):3955-64.
    View in: PubMed
    Score: 0.107
  15. A subviral particle binding domain on the rotavirus nonstructural glycoprotein NS28. Virology. 1993 Jun; 194(2):665-73.
    View in: PubMed
    Score: 0.100
  16. Characterization of serum antibody responses to natural rotavirus infections in children by VP7-specific epitope-blocking assays. J Clin Microbiol. 1992 May; 30(5):1056-61.
    View in: PubMed
    Score: 0.093
  17. Comparisons of rotavirus VP7-typing monoclonal antibodies by competition binding assay. J Clin Microbiol. 1992 Mar; 30(3):704-11.
    View in: PubMed
    Score: 0.091
  18. Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution. J Virol. 2011 Sep; 85(17):8635-45.
    View in: PubMed
    Score: 0.087
  19. Sequence of a rotavirus gene 4 associated with unique biologic properties. Arch Virol. 1991; 120(1-2):109-13.
    View in: PubMed
    Score: 0.084
  20. Rotavirus architecture at subnanometer resolution. J Virol. 2009 Feb; 83(4):1754-66.
    View in: PubMed
    Score: 0.073
  21. Tomato is a highly effective vehicle for expression and oral immunization with Norwalk virus capsid protein. Plant Biotechnol J. 2006 Jul; 4(4):419-32.
    View in: PubMed
    Score: 0.062
  22. Synthesis of a ricin toxin B subunit-rotavirus VP7 fusion protein in potato. Mol Biotechnol. 2006 Feb; 32(2):117-28.
    View in: PubMed
    Score: 0.060
  23. Synthesis and assembly of a cholera toxin B subunit-rotavirus VP7 fusion protein in transgenic potato. Mol Biotechnol. 2005 Nov; 31(3):193-202.
    View in: PubMed
    Score: 0.059
  24. pH-induced conformational change of the rotavirus VP4 spike: implications for cell entry and antibody neutralization. J Virol. 2005 Jul; 79(13):8572-80.
    View in: PubMed
    Score: 0.058
  25. Evolutionary trace residues in noroviruses: importance in receptor binding, antigenicity, virion assembly, and strain diversity. J Virol. 2005 Jan; 79(1):554-68.
    View in: PubMed
    Score: 0.056
  26. The VP7 outer capsid protein of rotavirus induces polyclonal B-cell activation. J Virol. 2004 Jul; 78(13):6974-81.
    View in: PubMed
    Score: 0.054
  27. A single nanobody neutralizes multiple epochally evolving human noroviruses by modulating capsid plasticity. Nat Commun. 2023 10 16; 14(1):6516.
    View in: PubMed
    Score: 0.051
  28. Novel fold of rotavirus glycan-binding domain predicted by AlphaFold2 and determined by X-ray crystallography. Commun Biol. 2022 05 05; 5(1):419.
    View in: PubMed
    Score: 0.046
  29. Initial interaction of rotavirus strains with N-acetylneuraminic (sialic) acid residues on the cell surface correlates with VP4 genotype, not species of origin. J Virol. 2002 Apr; 76(8):4087-95.
    View in: PubMed
    Score: 0.046
  30. Atomic structure of the predominant GII.4 human norovirus capsid reveals novel stability and plasticity. Nat Commun. 2022 03 10; 13(1):1241.
    View in: PubMed
    Score: 0.046
  31. Broadly cross-reactive human antibodies that inhibit genogroup I and II noroviruses. Nat Commun. 2021 07 14; 12(1):4320.
    View in: PubMed
    Score: 0.044
  32. Trypsin cleavage stabilizes the rotavirus VP4 spike. J Virol. 2001 Jul; 75(13):6052-61.
    View in: PubMed
    Score: 0.044
  33. High-Resolution Mapping of Human Norovirus Antigens via Genomic Phage Display Library Selections and Deep Sequencing. J Virol. 2020 12 09; 95(1).
    View in: PubMed
    Score: 0.042
  34. 2.7 ? cryo-EM structure of rotavirus core protein VP3, a unique capping machine with a helicase activity. Sci Adv. 2020 04; 6(16):eaay6410.
    View in: PubMed
    Score: 0.040
  35. Comparative amino acid sequence analysis of the outer capsid protein VP4 from four lapine rotavirus strains reveals identity with genotype P[14] human rotaviruses. Arch Virol. 1997; 142(5):1059-69.
    View in: PubMed
    Score: 0.032
  36. Detection of human norovirus in intestinal biopsies from immunocompromised transplant patients. J Gen Virol. 2016 09; 97(9):2291-2300.
    View in: PubMed
    Score: 0.031
  37. Antiviral targets of human noroviruses. Curr Opin Virol. 2016 06; 18:117-25.
    View in: PubMed
    Score: 0.031
  38. Characterization and replicase activity of double-layered and single-layered rotavirus-like particles expressed from baculovirus recombinants. J Virol. 1996 May; 70(5):2736-42.
    View in: PubMed
    Score: 0.031
  39. Rotavirus structure: interactions between the structural proteins. Arch Virol Suppl. 1996; 12:21-7.
    View in: PubMed
    Score: 0.030
  40. Rotavirus subunit vaccines. Arch Virol Suppl. 1996; 12:199-206.
    View in: PubMed
    Score: 0.030
  41. Human milk contains novel glycans that are potential decoy receptors for neonatal rotaviruses. Mol Cell Proteomics. 2014 Nov; 13(11):2944-60.
    View in: PubMed
    Score: 0.027
  42. Rotavirus VP3 expressed in insect cells possesses guanylyltransferase activity. Virology. 1992 May; 188(1):77-84.
    View in: PubMed
    Score: 0.023
  43. Specific interactions between rotavirus outer capsid proteins VP4 and VP7 determine expression of a cross-reactive, neutralizing VP4-specific epitope. J Virol. 1992 Jan; 66(1):432-9.
    View in: PubMed
    Score: 0.023
  44. Comparative study of the epidemiology of rotavirus in children from a community-based birth cohort and a hospital in South India. J Clin Microbiol. 2006 Jul; 44(7):2468-74.
    View in: PubMed
    Score: 0.015
  45. Rotavirus proteins: structure and assembly. Curr Top Microbiol Immunol. 2006; 309:189-219.
    View in: PubMed
    Score: 0.015
  46. Host, viral, and vaccine factors that determine protective efficacy induced by rotavirus and virus-like particles (VLPs). Vaccine. 2006 Feb 20; 24(8):1170-9.
    View in: PubMed
    Score: 0.015
  47. Diagnosis of norwalk virus infection by indirect enzyme immunoassay detection of salivary antibodies to recombinant norwalk virus antigen. Clin Diagn Lab Immunol. 2004 Nov; 11(6):1028-34.
    View in: PubMed
    Score: 0.014
  48. Inter- and intragenus structural variations in caliciviruses and their functional implications. J Virol. 2004 Jun; 78(12):6469-79.
    View in: PubMed
    Score: 0.013
  49. Rotavirus 2/6 viruslike particles administered intranasally with cholera toxin, Escherichia coli heat-labile toxin (LT), and LT-R192G induce protection from rotavirus challenge. J Virol. 1998 Apr; 72(4):3390-3.
    View in: PubMed
    Score: 0.009
  50. The N terminus of rotavirus VP2 is necessary for encapsidation of VP1 and VP3. J Virol. 1998 Jan; 72(1):201-8.
    View in: PubMed
    Score: 0.009
  51. Three-dimensional structural analysis of recombinant rotavirus-like particles with intact and amino-terminal-deleted VP2: implications for the architecture of the VP2 capsid layer. J Virol. 1997 Oct; 71(10):7353-60.
    View in: PubMed
    Score: 0.008
  52. Identification of the minimal replicase and the minimal promoter of (-)-strand synthesis, functional in rotavirus RNA replication in vitro. Arch Virol Suppl. 1996; 12:59-67.
    View in: PubMed
    Score: 0.007
  53. Characterization of rotavirus VP2 particles. Virology. 1994 May 15; 201(1):55-65.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.